U.S. markets closed

Medite Cancer Diagnostics, Inc. (MDIT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0255+0.0055 (+27.50%)
At close: 9:30AM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/14/2021
Current
Market Cap (intraday) 5
520.34k
Enterprise Value 3
7.44M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.04
Price/Book (mrq)
0.21
Enterprise Value/Revenue 3
0.92
Enterprise Value/EBITDA 6
-2.11

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3-50.00%
S&P500 52-Week Change 323.65%
52 Week High 30.0585
52 Week Low 30.0022
50-Day Moving Average 30.0177
200-Day Moving Average 30.0111

Share Statistics

Avg Vol (3 month) 39.74k
Avg Vol (10 day) 318.75k
Shares Outstanding 586.72M
Float 17.31M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Mar 11, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2017
Most Recent Quarter (mrq)Sep 29, 2018

Profitability

Profit Margin -65.49%
Operating Margin (ttm)-49.34%

Management Effectiveness

Return on Assets (ttm)-13.68%
Return on Equity (ttm)-73.70%

Income Statement

Revenue (ttm)8.13M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)42.00%
Gross Profit (ttm)162k
EBITDA -3.73M
Net Income Avi to Common (ttm)-5.42M
Diluted EPS (ttm)-0.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)90k
Total Cash Per Share (mrq)0
Total Debt (mrq)6.05M
Total Debt/Equity (mrq)94.00
Current Ratio (mrq)1.11
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-5.19M
Levered Free Cash Flow (ttm)-2.44M